According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032.
Checkpoint inhibitor refractory cancer occurs when tumors develop...
Cancer Immunotherapy Market Expands Rapidly as Precision Oncology and Advanced Biologic Therapies Transform Cancer Treatment
Overview
The Global Cancer Immunotherapy Market is witnessing substantial growth as healthcare providers, pharmaceutical companies, and research institutions increasingly focus on advanced immune-based therapies to improve cancer treatment outcomes. Cancer...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek